Top Markets
Coin of the day
Caregen Co., Ltd. Caregen Co., Ltd.

Caregen Co., Ltd.

214370
Rank in Stocks #6984
Caregen Co., Ltd. is primarily involved in the creation and development of... Caregen Co., Ltd. is primarily involved in the creation and development of biomimetic peptides. The company operates through distinct business segments, each catering to specific markets. Its Professional Therapy division engineers medical devices utilizing functional peptides and sophisticated sustained-release technology. Through its Cosmeceutical line, Caregen offers a variety of products for skin and hair care, including solutions for whitening, anti-inflammatory purposes, and those mimicking botulinum toxin functions. The Health Functional Food division provides dietary supplements specifically designed for blood control. Additionally, the Raw Material segment supplies essential peptide growth factors. Founded on August 17, 2001, the firm is headquartered in Anyang-si, South Korea.
Share Price
$36.37
Market Cap
$1.78B
Change (1 day)
-1.13%
Change (1 year)
-5.81%
Country
KR
Trade Caregen Co., Ltd. (214370)
Operating Margin for Caregen Co., Ltd. (214370)
Operating Margin as of 2026 TTM: 0.00%
According to Caregen Co., Ltd. latest financial reports and stock price the company's current Operating Margin (TTM) is 0.00%. At the end of 2026 the company had an Operating Margin of 0.00%.
Operating Margin history for Caregen Co., Ltd. from 2026 to 2026
Operating Margin at the end of each year
Year Operating Margin Change
Not enough data for the provided dates.
Operating Margin for similar companies or competitors
Company Operating Margin Operating Margin Difference Country
25.56% -
JP
6.22% -
TW
0.00% -
DE
5.98% -
SA
-0.42% -
CN
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.